Treating paracetamol overdose by charcoal haemoperfusion and long-hours high-flux dialysis

QJM: An International Journal of Medicine

Volumn 89, Issue 4, 1996, Pages 297-306

  Higgins, R M ^a,b   Goldsmith, D J A ^a   MacDiarmid Gordon, A ^a   Taberner, D ^a   Venning, M C ^a   Ackrill, P ^a  

^a WITHINGTON HOSPITAL   (United Kingdom)

^b WALSGRAVE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; BILIRUBIN; CHARCOAL; CREATININE; PARACETAMOL;

ADOLESCENT; ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; CREATININE BLOOD LEVEL; DIALYSIS; DISEASE SEVERITY; DRUG OVERDOSE; FEMALE; HEMOPERFUSION; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROTHROMBIN TIME; RISK;

EID: 0029942598     PISSN: 00335622     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/89.4.297     Document Type: Article

References (43)

1. Davidson DCD, Eastham WN. Acute liver necrosis following overdose of paracetamol. Br Med J 1966; ii:497-9.
2. Hawton K, Fagg J. Trends in deliberate self poisoning and self injury in Oxford, 1976-90. Br Med J 1992; 304:1409-11.
3. Prescott LF, Illingworth RN, Critchley JAJH, Stewart MJ, Adam RD, Proudfoot AT. Intravenous N-acetylcysteine: treatment of choice for paracetamol poisoning. Br Med J 1979; ii:1097-120.
4. Harrison PM, Keays R, Bray GP, Alexander GJM, Williams R. Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine. Lancet 1990; 335:1572-3.
5. Keays R, Harrison PM, Wendon JA, Forbes A, Gove C, Alexander GJM, Williams R. Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial. Br Med J 1991; 303:1026-9.
6. O'Grady JG, Wendon J, Tan KC, Potter D, Cottam S, Cohen AT, Gimson AES, Williams R. Liver transplantation after paracetamol overdose. Br Med J 1991; 303:221-3.
7. Widdop B, Medd RK, Braithwaite RA, Rees AJ, Goulding R. Experimental drug intoxication: treatment with charcoal haemoperfusion. Arch Toxicol 1975; 34:27-36.
8. Winchester JF, Edwards RO, Tilstone WJ, Woodcock BG. Activated charcoal hemoperfusion and experimental acetaminophen poisoning. Toxicol Applied Pharmacol 1975; 31:120-7.
9. Helliwell M. Severe barbiturate and paracetamol overdose: the simultaneous removal of both poisons by haemoperfusion. Postgrad Med J 1980; 56:363-5.
10. Helliwell M, Essex E. Hemoperfusion in 'late' paracetamol poisoning. Clin Toxicol 1981; 18:1225-33.
11. Raper S, Crome P, Vale A, Helliwell M. Experience with activated carob-bead haemoperfusion columns in the treatment of severe drug intoxication. Arch Toxicol 1982; 49:303-10.
12. Rigby RJ, Thomson NM, Parkin GW, Cheung TPF. The treatment of paracetamol overdose with haemoperfusion and cysteamine. Med J Aust 1978, 1:396-9.
13. Westman L. N-acetylcysteine in the treatment of acetaminophen overdose. N Engl J Med 1989; 320:1417.
14. Willson RA, Winch J, Thompson RPH, Williams R. Rapid removal of paracetamol by haemoperfusion through coated charcoal. Lancet 1974; i:77-9.
15. Winchester JF, Gelfand MC, Helliwell M, Vale JA, Goulding R, Schreiner GE. Extracorporeal treatment of salicylate or acetaminophen poisoning - is there a role? Arch Int Med 1981; 141:370-4.
16. Vale JA, Rees AJ, Widdop B, Goulding R. Use of charcoal haemoperfusion in the management of severely poisoned patients. Br Med J 1975; i:5-9.
17. Gazzard BG, Willson RA, Weston MJ, Thompson RPH, Williams R. Charcoal haemoperfusion for paracetamol overdose. Br J Clin Pharmacol 1974; 1:271-5.
18. McBride PV, Rumack BH. Acetaminophen intoxication. Semin Dialysis 1992; 5:292-8.
19. Webb D. Charcoal haemoperfusion in drug intoxication. Br J Hosp Med 1993; 49:493-6.
20. Gimson AES, Braude S, Mellon PJ, Canalese J, Williams R. Earlier charcoal haemoperfusion in fulminant hepatic failure. Lancet 1982; ii:681-3.
21. O'Grady JG, Gimson AES, O'Brien CJ, Pucknell A, Hughes RD, Williams R. Controlled trials of charcoal haemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology 1988; 94:1186-92.
22. O'Grady JC, Alexander GJM, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97.439-45.
23. Gazzard BG, Hughes RD, Widdop B, Goulding R, Davis M, Williams R. Early prediction of the outcome of paracetamol overdose based on analysis of 163 patients. Postgrad Med J 1977; 53:243-7.
24. Harrison PM, O'Grady JG, Keays RT, Alexander GJM, Williams R. Serial prothrombin time as a prognostic indicator in paracetamol induced fulminant hepatic failure. Br Med J 1990; 301:964-6.
25. Prescott LF, Wright N, Roscoe P, Brown SS. Plasma paracetamol half-life and hepatic necrosis in patients with paracetamol overdosage. Lancet 1971; i:519-21.
26. Gazzard BG, Portmann B, Weston MJ, Langley PG, Murray-Lyon IM, Dunlop EH, Flax H, Mellon PJ, Record CO, Ward MB, Williams R. Charcoal haemoperfusion in the treatment of fulminant hepatic failure. Lancet 1974; 1:1301-7.
27. Prescott LF, Wright N. The effects of hepatic and renal damage on paracetamol metabolism and excretion following overdosage. A pharmacokinetic study. Br J Pharmacol 1973; 49:602-13.
28. Kumar S, Rex DK. Failure of physicians to recognise acetaminophen toxicity in chronic alcoholics. Arch Int Med 1991; 151:1189-91.
29. Seeff LB, Cuccherini BA, Zimmermann HJ, Alder E, Benjamin SB. Acetaminophen toxicity in alcoholics. Ann Intern Med 1986; 104:399-404.
30. Sherlock S. The spectrum of hepatotoxicity due to drugs. Lancet 1986; ii:440-4.
31. Beckett GJ, Chapman BJ, Dyson EH, Hayes JD. Plasma glutathione S-transferase measurements after paracetamol overdose: evidence for early hepatocellular damage. Cut 1985; 26:26-31.
32. Portmann B, Talbot IC, Day DW, Davidson AR, Murray-Lyon IM, Williams R. Histopathological changes in the liver following a paracetamol overdose: correlation with clinical and biochemical parameters. J Pathol 1975; 117:169-81.
33. Silk DBA, Hanid MA, Trewby PN, Davies M, Chase RA, Langley PC, Mellon PJ, Wheeler PC, Williams R. Treatment of fulminant hepatic failure by polyacrylonitrile membrane haemodralysis. Lancet 1977; ii:1-3.
34. Quarto di Palo F, Buccianti C, Polli EE. Polyacrylonitrile membrane dialysis for hepatic coma. Lancet 1977; ii:451-2.
35. Davenport A, Will EJ, Losowsky MJ, Swindells S. Continuous arteriovenous haemofiltration in hepatic encephalopathy and renal failure. Br Med J 1987; 295:1028.
36. Dymock IW, Tucker JS, Woolf IL, Poller L, Thomson JM. Coagulation studies as a prognostic index in acute liver failure. Br J Haematol 1975; 29:385-95.
37. Gazzard BG, Henderson JM, Williams R. Factor VII levels as a guide to prognosis in fulminant hepatic failure. Cut 1976; 17:489-91.
38. Pereira LMMB, Langley PC, Hayllar KM, Tredeger JM, Williams R. Coagulation factor V and VIII/V ratio as predictors of outcome in paracetamol induced fulminant hepatic failure: relation to other prognostic factors. Cut 1992; 33:98-101.
39. Bunker VW, Clayton BE. Selenium status in disease: the role of selenium as a therapeutic agent. Br J Clin Practice 1990; 44:401-3.
40. Valimaki M, Alfthan G, Pikkarainen J, Yikahri R, Salapuspuro. Blood and liver selenium concentrations in patients with liver diseases. Clinica Chemica Acta 1987; 166:171-6.
41. Aaseth J, Thomassen Y, Norheim C. Decreased serum selenium in alcoholic cirrhosis. N Engl J Med 1980; 303:945.
42. Valimaki M, Alfthan G, Vuoristo M, Yikahri R. Effects of selenium supplementation on blood and urine selenium levels and liver function in patients with primary biliary cirrhosis. Clinica Chemica Acta 1991; 196:7-16.
43. Peterson FJ, Lindemann NJ, Duquette PH, Holtzman JL. Potentiation of acute acetaminophen lethality by selenium and vitamin E deficiency in mice. J Nutr 1992; 122:74-81.